Generation Bio Co.
CLOSED-ENDED DNA (CEDNA) AND IMMUNE MODULATING COMPOUNDS

Last updated:

Abstract:

Provided herein are methods and constructs related to minimizing immune responses using modified dexamethasone compounds when administering a desired transgene in a cell achieved by delivery of the transgene with one or more doses of a ceDNA construct.

Status:
Application
Type:

Utility

Filling date:

6 Mar 2020

Issue date:

16 Jun 2022